Citadel Advisors LLC 13D/13G Filings for Relmada Therapeutics, Inc. (RLMD)

Citadel Advisors LLC 13D and 13G filings for Relmada Therapeutics, Inc.:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Shares have been adjusted for stock splits.
Time period
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2023-02-14
08:14 am
Sale
2022-12-3113GRelmada Therapeutics, Inc.
RLMD
Citadel Advisors LLC511,316
1.700%
-823,557decrease
(-61.70%)
Filing
2022-10-17
4:08 pm
Purchase
2022-10-0713GRelmada Therapeutics, Inc.
RLMD
Citadel Advisors LLC1,334,873
4.400%
1,334,873increase
(New Position)
Filing